Immutep Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PRRUF | IMU.AX | HURA | ESLA | HBP.TO | CHRS | |
|---|---|---|---|---|---|---|
| Market cap | 29.47M | 19.39M | 106.10M | 17.84M | 70.27M | 114.55M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.9 | -2.8 | -1.3 | -8.4 | -1.2 |
| Price/book | 0.7 | 1.6 | 5.8 | -2.4 | 4.8 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −90.00% | −91.04% | −29.80% | −83.91% | −54.68% | −42.95% |
| Today | 0.00% | +16.67% | −3.20% | −7.51% | 0.00% | −12.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All PRRUF news ›Layoff Tracker: Immutep, Molecular cut workforces
Taylor Tieden for BioSpace Below is a look at which companies are tightening their belts and cutting staff in 2026. For last year’s tracker entries, please visit the 2025 recap article. To see which biopharmas laid off employees in the…
Autoimmune Pivot: Can Immutep (ASX:IMM) Rewrite Its Story?
Has Gold Bottomed? What It Means for ASX 200's Ramelius (ASX:RMS) Unhedged and Exposed: Why Is ASX 200's Capricorn (ASX:CMM) on Watch? The month brings several scheduled events that could shape how the market views Immutep. The…
Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026
The investigators concluded that the regimen demonstrated “no significant detriment to overall QoL during treatment”. The ePoster is available on the Posters & Publications page of Immutep’s website. About Eftilagimod Alfa (Efti) Efti’s…
Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026
Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP) OpenWorld (NASDAQ: OPNW) Signs Definitive Merger…
Daily Special: Clever Culture Systems, Aureka, Immutep, Clean TeQ Water, Dundas Minerals
Sharecafe Daily Special: Clever Culture Systems, Aureka, Immutep, Clean TeQ Water, Dundas Minerals The Australian sharemarket extended its losses on Wednesday, with the S&P/ASX 200 falling 72.4 points, or 0.82
Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research
The project will use structural biology, cellular immunology and advanced imaging to investigate immune regulation. The research builds on the collaboration’s human LAG-3/MHC Class II crystal structure published in December 2024. Immutep…
Immutep regains Nasdaq bid-price compliance
The ADS ratio adjustment changed the number of ordinary shares represented by each ADS, while leaving Immutep’s ordinary shares unaffected. PURSUANT TO RULE 13a-16 OR 15d-16 Date as October 13, 2026 (Exact Name as Specified in its Charter)…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net3
- biospace.com2
- globenewswire.com1
- kalkinemedia.com1
- sharecafe.com.au1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.